These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1167045)

  • 21. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lyell's toxic epidermal necrolysis: a staphylococcal aetiology?
    Jefferson J
    Br Med J; 1967 Jun; 2(5555):802-4. PubMed ID: 6029142
    [No Abstract]   [Full Text] [Related]  

  • 23. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.
    Yang SC; Hu S; Zhang SZ; Huang JW; Zhang J; Ji C; Cheng B
    J Immunol Res; 2018; 2018():4320195. PubMed ID: 29607330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
    Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxic epidermal necrolysis in children. (Description of 4 cases).
    Messaritakis J
    Ann Paediatr; 1966; 207(4):236-46. PubMed ID: 4225129
    [No Abstract]   [Full Text] [Related]  

  • 26. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic epidermal necrolysis: examining a multifaceted enigma.
    Binnick SA; Pirozzi DJ
    Postgrad Med; 1975 Oct; 58(4):126-30. PubMed ID: 1099565
    [No Abstract]   [Full Text] [Related]  

  • 28. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
    Hsu DY; Brieva J; Silverberg NB; Paller AS; Silverberg JI
    J Am Acad Dermatol; 2017 May; 76(5):811-817.e4. PubMed ID: 28285784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic epidermal necrolysis: the scalded skin syndrome.
    Anderson JP; Hillman DA
    Can Med Assoc J; 1966 Nov; 95(21):1076-80. PubMed ID: 5926269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impetigo contagiosa: a comparison of erythromycin and dicloxacillin therapy.
    Barton LL; Friedman AD; Portilla MG
    Pediatr Dermatol; 1988 May; 5(2):88-91. PubMed ID: 3045781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Trial in pediatrics of a new antibiotic association: dicloxacillin and ampicillin].
    Dianese G
    Minerva Pediatr; 1972 May; 24(17):711-21. PubMed ID: 5029622
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
    Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
    Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the clinical experience of a University Hospital (1989-2008)].
    Ferrándiz-Pulido C; García-Fernández D; Gómez-Morell P; Palao R; García-Patos V
    Med Clin (Barc); 2011 May; 136(13):583-7. PubMed ID: 21414644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical trials of the use of the ampicillin-dicloxacillin combination in children].
    Arioni G; Cozzani Livolsi E; Gilardi A
    Minerva Pediatr; 1974 Apr; 26(12):622-34. PubMed ID: 4456197
    [No Abstract]   [Full Text] [Related]  

  • 37. Staphylococcal induced toxic epidermal necrolysis in an adult: case report.
    Schlesinger JJ
    Mil Med; 1977 Oct; 142(10):791-3. PubMed ID: 411067
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with a combined treatment with ampicillin and dicloxacillin in children].
    Krey WD
    Munch Med Wochenschr; 1970 Dec; 112(49):2252-5. PubMed ID: 5536818
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic epidermal necrolysis and Stevens-Johnson's disease.
    Ohlenschlaeger K
    Acta Derm Venereol; 1966; 46(2):204-9. PubMed ID: 4162642
    [No Abstract]   [Full Text] [Related]  

  • 40. Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments.
    Elias PM; Fritsch P; Epstein EH
    Arch Dermatol; 1977 Feb; 113(2):207-19. PubMed ID: 836697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.